[1]LI GZ,DOHERTY GM,WANG J.Surgical management of gastric cancer:A review[J].JAMA Surg,2022,157(5):446-454.
[2]LORDICK F,CARNEIRO F,CASCINU S,et al.Electronic address:clinicalguidelines@esmo.org.Gastric cancer:ESMO Clinical Practice Guideline for diagnosis,treatment and follow-up[J].Ann Oncol,2022,33(10):1005-1020.
[3]CAO Y,FAN L,LI L,et al.Propofol suppresses cell proliferation in gastric cancer cells through NRF2-mediated polyol pathway[J].Clin Exp Pharmacol Physiol,2022,49(2):264-274.
[4]INTERLANDI C,DI PS,COSTA GL,et al.Effects of cisatracurium in sevoflurane and propofol requirements in dog-undergoing-mastectomy surgery[J].Animals (Basel),2022,12(22):3134.
[5]ZHOU Q,YUAN J,LIU Y,et al.Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling[J].Bioengineered,2021,12(2):11213-11224.
[6]LYU W,WANG J,ZHANG S.Effects of cisatracurium on epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma[J].Oncol Lett,2019,18(5):5325-5331.
[7]ZHANG X,ZHENG X.Hsa_circ_0001495 contributes to cervical cancer progression by targeting miR-526b-3p/TMBIM6/mTOR axis[J].Reprod Biol,2022,22(2):100648.
[8]WU M,LI X,LIU Q,et al.miR-526b-3p serves as a prognostic factor and regulates the proliferation,invasion,and migration of glioma through targeting WEE1[J].Cancer Manag Res,2019,11(1):3099-3110.
[9]LIU J,CHEN S,CHEN Y,et al.High expression of FMNL3 associates with cancer cell migration,invasion,and unfavorable prognosis in tongue squamous cell carcinoma[J].J Oral Pathol Med,2019,48(6):459-467.
[10]WU Y,SHEN Z,WANG K,et al.Author correction:High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis:role in TGF-β1-induced epithelia-to-mesenchymal transition[J].Sci Rep,2022,12(1):5180.
[11]YIN G,TIAN P,BU HA,et al.LncRNA LINC00689 promotes the progression of gastric cancer through upregulation of ADAM9 by sponging miR-526b-3p[J].Cancer Manag Res,2020,12(3):4227-4239.
[12]夏明,徐建国.麻醉药物与肿瘤转移[J].临床麻醉学杂志,2019,35(5):515-517.
XIA M,XU JG.Anesthetics and tumor metastasis[J].Journal of Clinical Anesthesiology,2019,35(5):515-517.
[13]CAO Q,TIAN X,DONG C,et al.Effects of different doses of cisatracurium besilate on hemodynamics and postoperative cognitive function in patients undergoing radical resection of lung cancer[J].Oncol Lett,2019,18(2):1761-1766.
[14]ZHU D,SHI C,JIANG Y,et al.Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21[J].Bioengineered,2021,12(1):1505-1516.
[15]YABSIN IB,LU ZL,YU JC,et al.Cisatracurium-induced proliferation impairment and death of colorectal cancer cells,HCT116 is mediated by p53 dependent intrinsic apoptotic pathway in vitro[J].Biomed Pharmacother,2017,91(14):320-329.
[16]YANG X,MA W.Cisatracurium inhibits the proliferation,migration and invasion of breast cancer cells by regulating the expression of miR-3174[J].Cell Mol Biol (Noisy-le-grand),2020, 66(6):1-7.
[17]周霞,刘德智,孟瑞霞,等.顺阿曲库铵通过调控miR-3666表达抑制膀胱癌细胞的增殖、迁移和侵袭[J].中国老年学杂志,2022,42(23):5766-5770.
ZHOU X,LIU DZ,MENG RX,et al.Ciatracurium inhibits the proliferation,migration and invasion of bladder cancer cells by regulating the expression of miR-3666[J].Chinese Journal of Gerontology,2022,42(23):5766-5770.
[18]ZHAO X,FU L,ZHAI L,et al.MiR-526b targets lncRNA SLC16A1-AS1 to suppress cell proliferation in triple-negative breast cancer[J].J Biochem Mol Toxicol,2023,18(2):e23247.
[19]LIU Y,XIAO X,WANG J,et al.Silencing circEIF3I/miR-526b-5p axis epigenetically targets HGF/c-Met signal to hinder the malignant growth,metastasis and angiogenesis of hepatocellular carcinoma[J].Biochem Genet,2023,61(1):48-68.
[20]ZHANG X,ZHENG X.Hsa_circ_0001495 contributes to cervical cancer progression by targeting miR-526b-3p/TMBIM6/mTOR axis[J].Reprod Biol,2022,22(2):100648.
[21]WU Z,QIU X,GAO B,et al.Melatonin-mediated miR-526b-3p and miR-590-5p upregulation promotes chondrogenic differentiation of human mesenchymal stem cells[J].J Pineal Res,2018,65(1):e12483.
[22]王晓微,侯俊德,王志刚,等.右美托咪定调控miR-526b-3p/S100A4表达影响胰腺癌细胞增殖及凋亡的机制研究[J].中国药师,2020,23(8):1519-1524.
WANG XW,HOU JD,WANG ZG,et al.Study on the mechanism of dexmedetomidine regulating the expression of miR-526b-3p/S100A4 to affect the proliferation and apoptosis of pancreatic cancer cells[J].Chinese Herbalist,2020,23(8):1519-1524.
[23]ZHANG Q,NIE H,PAN J,et al.FMNL3 is overexpressed in tumor tissues and predicts an immuno-hot phenotype in pancreatic cancer[J]. Int J Gen Med,2022,15(3):8285-8298.
[24]WANG W,XU S,DI Y,et al.Novel role of LINC01013/miR-6795-5p/FMNL3 axis in the regulation of hepatocellular carcinoma stem cell features[J].Acta Biochim Biophys Sin (Shanghai),2021,53(6):652-662.
[25]CHUA OD,PROUNGVITAYA T,TECHASEN A,et al.Bioinformatic prediction of novel signaling pathways of apoptosis-inducing factor,mitochondrion-associated 3 (AIFM3) and their roles in metastasis of cholangiocarcinoma cells[J].Cancer Genomics Proteomics,2022,19(1):35-49.
[26]GARDBERG M,HEUSER VD,KOSKIVUO I,et al.FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome[J].J Pathol Clin Res,2016,2(1):41-52.
[27]GAO X,WANG X,CAI K,et al.MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3[J].Eur J Pharmacol,2016,791(1):603-610.